Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-02

Clinical Trial Update: Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of Brivudine for treating herpes zoster. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brivudine (brivudine)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Herpes Zoster | Phase 4 | Status: RECRUITING